Topical sulforaphane exacerbates disease and promotes the accumulation of inflammatory CD8+ T cells in a dermatitis model
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by skin barrier dysfunction and immune activation. Antioxidants such as sulforaphane (SFN) have shown benefit in mouse models of AD and are being explored as topical therapies. Objectives: We investigated the immune mechanisms through which topical SFN affects skin pathology in the MC903-induced AD-like…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
